Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Resistance, Neoplasm | 12 | 2021 | 5148 | 0.900 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 3 | 2020 | 103 | 0.760 |
Why?
|
Melanoma | 6 | 2022 | 5446 | 0.750 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2021 | 200 | 0.730 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2020 | 2196 | 0.640 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11410 | 0.560 |
Why?
|
Urinary Bladder | 1 | 2017 | 1153 | 0.400 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2016 | 778 | 0.350 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4463 | 0.310 |
Why?
|
Carcinoma | 1 | 2017 | 2361 | 0.270 |
Why?
|
Tumor Escape | 2 | 2019 | 348 | 0.270 |
Why?
|
Skin Neoplasms | 3 | 2020 | 5632 | 0.270 |
Why?
|
DNA Mismatch Repair | 2 | 2019 | 423 | 0.270 |
Why?
|
Immunotherapy | 5 | 2021 | 4391 | 0.250 |
Why?
|
Adenocarcinoma | 2 | 2017 | 6318 | 0.210 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4832 | 0.200 |
Why?
|
Mutation | 11 | 2021 | 29658 | 0.200 |
Why?
|
Neoplasm Invasiveness | 3 | 2018 | 3603 | 0.190 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2020 | 29 | 0.190 |
Why?
|
Furans | 1 | 2021 | 186 | 0.190 |
Why?
|
Ketones | 1 | 2021 | 182 | 0.190 |
Why?
|
Cyclic AMP Response Element-Binding Protein A | 1 | 2019 | 21 | 0.180 |
Why?
|
Sesquiterpenes | 1 | 2020 | 176 | 0.180 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 374 | 0.180 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2020 | 2015 | 0.170 |
Why?
|
Neurofibromin 1 | 1 | 2020 | 195 | 0.170 |
Why?
|
Androgen Receptor Antagonists | 1 | 2019 | 112 | 0.170 |
Why?
|
Cisplatin | 3 | 2020 | 1617 | 0.160 |
Why?
|
Gene Fusion | 1 | 2021 | 371 | 0.160 |
Why?
|
DNA Repair | 4 | 2020 | 2030 | 0.160 |
Why?
|
Antigen Presentation | 2 | 2021 | 1286 | 0.150 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 508 | 0.150 |
Why?
|
Nucleotides | 1 | 2020 | 461 | 0.150 |
Why?
|
Melanoma, Experimental | 1 | 2020 | 562 | 0.150 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2019 | 171 | 0.150 |
Why?
|
Neoplasm Proteins | 2 | 2020 | 3694 | 0.140 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2022 | 721 | 0.140 |
Why?
|
Radiation Tolerance | 1 | 2019 | 486 | 0.140 |
Why?
|
Prostatic Neoplasms | 4 | 2021 | 10999 | 0.140 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3562 | 0.140 |
Why?
|
Neoadjuvant Therapy | 2 | 2017 | 2688 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2018 | 322 | 0.140 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 797 | 0.140 |
Why?
|
Lung Neoplasms | 2 | 2017 | 12985 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2018 | 528 | 0.130 |
Why?
|
Microsatellite Instability | 1 | 2018 | 673 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8400 | 0.120 |
Why?
|
Tumor Microenvironment | 3 | 2021 | 3508 | 0.120 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1603 | 0.120 |
Why?
|
Neoplasms | 5 | 2021 | 21507 | 0.120 |
Why?
|
Antineoplastic Agents | 4 | 2021 | 13635 | 0.120 |
Why?
|
Databases, Genetic | 2 | 2018 | 1777 | 0.120 |
Why?
|
Phylogeny | 1 | 2021 | 2789 | 0.120 |
Why?
|
Gene Silencing | 1 | 2020 | 1537 | 0.120 |
Why?
|
Cystectomy | 1 | 2017 | 675 | 0.110 |
Why?
|
Muscle, Smooth | 1 | 2016 | 929 | 0.110 |
Why?
|
Antigens, Neoplasm | 2 | 2019 | 1977 | 0.100 |
Why?
|
Oncogenes | 1 | 2018 | 1264 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2018 | 2552 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 2 | 2018 | 5502 | 0.100 |
Why?
|
Bone Marrow | 2 | 2019 | 2933 | 0.100 |
Why?
|
DNA, Neoplasm | 1 | 2017 | 1754 | 0.100 |
Why?
|
Cell Survival | 1 | 2021 | 5877 | 0.100 |
Why?
|
Humans | 31 | 2022 | 739398 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1522 | 0.090 |
Why?
|
Receptors, Androgen | 3 | 2021 | 1049 | 0.090 |
Why?
|
Survival Rate | 3 | 2021 | 12761 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2021 | 4424 | 0.090 |
Why?
|
Rectal Neoplasms | 1 | 2019 | 1192 | 0.090 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2019 | 1050 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4182 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4791 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1957 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2019 | 6726 | 0.080 |
Why?
|
Treatment Outcome | 4 | 2021 | 62693 | 0.080 |
Why?
|
Cohort Studies | 4 | 2018 | 40389 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3506 | 0.080 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7709 | 0.070 |
Why?
|
Male | 13 | 2021 | 349022 | 0.070 |
Why?
|
Cell Line, Tumor | 5 | 2020 | 16646 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2727 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2021 | 2948 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2020 | 1867 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6082 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2530 | 0.060 |
Why?
|
Receptors, Immunologic | 2 | 2020 | 1424 | 0.060 |
Why?
|
Mice, SCID | 2 | 2020 | 2716 | 0.060 |
Why?
|
Genomics | 4 | 2021 | 5652 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7862 | 0.060 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9387 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9122 | 0.050 |
Why?
|
Genome | 2 | 2022 | 1794 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19811 | 0.050 |
Why?
|
Signal Transduction | 3 | 2021 | 23355 | 0.050 |
Why?
|
Female | 8 | 2021 | 378853 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10142 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 250 | 0.050 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3433 | 0.050 |
Why?
|
Prognosis | 2 | 2019 | 28901 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57650 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2020 | 288 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2019 | 316 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 703 | 0.040 |
Why?
|
Phenylthiohydantoin | 1 | 2019 | 190 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2933 | 0.040 |
Why?
|
Aged | 6 | 2021 | 162698 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6722 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 727 | 0.040 |
Why?
|
Spliceosomes | 1 | 2018 | 110 | 0.040 |
Why?
|
Cullin Proteins | 1 | 2018 | 180 | 0.040 |
Why?
|
Receptors, Progesterone | 1 | 2021 | 1094 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1721 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3571 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 810 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 549 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2018 | 375 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 705 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1029 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11347 | 0.030 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2019 | 570 | 0.030 |
Why?
|
Nitriles | 1 | 2019 | 946 | 0.030 |
Why?
|
Middle Aged | 5 | 2021 | 212863 | 0.030 |
Why?
|
Estrogens | 1 | 2021 | 1561 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2019 | 1537 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20676 | 0.030 |
Why?
|
Benzamides | 1 | 2019 | 1374 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2018 | 719 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 982 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3119 | 0.030 |
Why?
|
Muscles | 1 | 2018 | 1608 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2021 | 2183 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2711 | 0.030 |
Why?
|
Adult | 4 | 2021 | 213394 | 0.030 |
Why?
|
Immunity | 1 | 2018 | 1008 | 0.030 |
Why?
|
Mice | 4 | 2020 | 81002 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1674 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3692 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 1936 | 0.020 |
Why?
|
Androgens | 1 | 2018 | 1270 | 0.020 |
Why?
|
Animals | 5 | 2020 | 168368 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2018 | 1997 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2419 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4555 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2141 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2409 | 0.020 |
Why?
|
Pedigree | 1 | 2016 | 4640 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1786 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6871 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4419 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5863 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7298 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9314 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10247 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4269 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3614 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 15987 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14558 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15036 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13237 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 71974 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18003 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21863 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17384 | 0.010 |
Why?
|
Transcription Factors | 1 | 2018 | 12120 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23294 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 38942 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40050 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53037 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20055 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 76631 | 0.010 |
Why?
|
Concepts
(170)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(119)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_